VBRI Hosts Sickle Cell Transfusion Pioneer Stella Chou for Aster Lecture
Versiti Blood Research Institute posted on LinkedIn:
”Last month, VBRI had the honor of hosting Stella T. Chou for the 20th annual Aster Lecture on Transfusion Medicine.
Dr. Chou is an associate professor of pediatrics at the Perelman School of Medicine at the University of Pennsylvania and Chief of the Division of Transfusion Medicine at the Children’s Hospital of Philadelphia. She practices both pediatric hematology and transfusion medicine with a particular focus on patients with sickle cell disease. As part of that dedication, she chaired the American Society of Hematology clinical guideline panel for transfusion management and advocates for improved transfusion care.
She’s advancing the field of sickle cell research through her work in RH genetic matching of red blood cells, integrating molecular technologies into medical practice, and developing new tools for blood banks.
In her presentation “Redefining Transfusion Medicine: Stem Cell-Derived RBCs and Precision RH Matching,” Dr. Chou shared her expertise and insights on:
• Red cell transfusion therapy and alloimmunization risks in sickle cell disease
• The role of RH genetic variation in alloimmunization
• Transfusion support advancements for patients
Events like this show how collaboration drives discovery. We’re grateful to Dr. Chou for visiting VBRI and sharing her expertise. Thank you to everyone who joined for this fascinating lecture.”
Keep up with Hemostasis Today
-
Dec 2, 2025, 10:06Maeva May Shares Stroke Association’s New Research Strategy that Launched at UKSF2025
-
Dec 2, 2025, 10:00Jennifer Ficenec: What Happens to Blood Products After Hospitals Say No?
-
Dec 2, 2025, 09:55Marilena Vrana Reflects on A Year of Growth, Gratitude, and Collective Strength
-
Dec 2, 2025, 09:51Time to Refocus on NSTEMI․ Why This State-of-the-Art Review Matters
-
Dec 2, 2025, 09:51Arsène Mekinian: Corticosteroid Tapering Strategies Show No Difference
-
Dec 2, 2025, 09:50Joanna Sadowska: Bayer’s Asundexian Reduces Ischemic Stroke Risk in Phase 3 Trial
-
Dec 2, 2025, 09:49George Touma: Sirolimus DCBs Will Eventually Replace Paclitaxel
-
Dec 2, 2025, 09:49Professor Erwin Loh: Amino Acid Reduces Alzheimer’s Plaques
-
Dec 2, 2025, 09:47How does the ISBT Mentorship Platform Work ?